EUVIMEDEUVIMED entdecken
Multizentrische Studie

ViT‐based quantification of intratumoral heterogeneity for predicting the early recurrence in HCC following multiple ablation

Ke Zhang, Jinyu Ru, Wenbo Wang, Min Xu, Lei Mu, Jinhua Pan, Jionghui Gu, Haoyan Zhang, Jie Tian iD, Wei Yang, Tianan Jiang, Kun Wang iD

Liver International · 2025

DOI: 10.1111/liv.16051 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Liver International, 2025. Verfasst von Ke Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasm Recurrence, Local, Ablation Techniques. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study aimed to develop a quantitative intratumoral heterogeneity (ITH) model for assessing the risk of early recurrence (ER) in pre‐treatment multimodal imaging for hepatocellular carcinoma (HCC) patients undergoing ablation treatments.

Methods

This multi‐centre study enrolled 633 HCC patients who underwent ultrasound‐guided local ablation between January 2015 and September 2022. Among them, 422, 85, 57 and 69 patients underwent radiofrequency ablation (RFA), microwave ablation (MWA), laser ablation (LA) and irreversible electroporation (IRE) ablation, respectively. Vision‐Transformer‐based quantitative ITH (ViT‐Q‐ITH) features were extracted from the US and MRI sequences. Multivariable logistic regression analysis was used to identify variables associated with ER. A combined model integrated clinic‐radiologic and ViT‐Q‐ITH scores. The prediction performance was evaluated concerning calibration, clinical usefulness and discrimination.

Results

The final training cohort and internal validation cohort included 318 patients and 83 patients, respectively, who underwent RFA and MWA. The three external testing cohorts comprised of 106 patients treated with RFA, 57 patients treated with LA and 69 patients who underwent IRE ablation. The combined model showed excellent predictive performance for ER in the training (AUC: .99, 95% CI: .99–1.00), internal validation (AUC: .86, 95% CI: .78–.94), external testing (AUC: .83, 95% CI: .73–.92), LA (AUC: .84, 95% CI: .73–.95) and IRE (AUC: .82, 95% CI: .72–.93) cohorts, respectively. Decision curve analysis further affirmed the clinical utility of the combined model.

Conclusions

The multimodal‐based model, incorporating clinic‐radiologic factors and ITH features, demonstrated superior performance in predicting ER among early‐stage HCC patients undergoing different ablation modalities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsNeoplasm Recurrence, LocalAblation TechniquesHumansMaleFemaleMiddle AgedAgedMagnetic Resonance ImagingRadiofrequency AblationRetrospective StudiesCatheter AblationRisk AssessmentLaser TherapyLogistic ModelsMultimodal Imaging

Stichwörter der Autor:innen

Intratumoral heterogeneityVision‐Transformerablation treatmentsearly recurrencehepatocellular carcinoma

Autor:innen und Institutionen

  • Department of Ultrasound Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, China.
  • School of Artificial Intelligence, University of Chinese Academy of Sciences, Beijing, China.
  • Department of Ultrasound, Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, China.
  • School of Engineering Medicine, Beihang University, Beijing, China.

ORCID-Profile: Jie Tian, Kun Wang

Zitieren

APA

Zhang, K., Ru, J., Wang, W., Xu, M., Mu, L., Pan, J., Gu, J., Zhang, H., Tian, J., Yang, W., Jiang, T., & Wang, K. (2025). ViT‐based quantification of intratumoral heterogeneity for predicting the early recurrence in HCC following multiple ablation. Liver International. https://doi.org/10.1111/liv.16051

Vancouver

Zhang K, Ru J, Wang W, Xu M, Mu L, Pan J, et al. ViT‐based quantification of intratumoral heterogeneity for predicting the early recurrence in HCC following multiple ablation. Liver International. 2025. doi:10.1111/liv.16051

BibTeX
@article{Zhang2025,
  author = {Zhang, Ke and Ru, Jinyu and Wang, Wenbo and Xu, Min and Mu, Lei and Pan, Jinhua and Gu, Jionghui and Zhang, Haoyan and Tian, Jie and Yang, Wei and Jiang, Tianan and Wang, Kun},
  title = {ViT‐based quantification of intratumoral heterogeneity for predicting the early recurrence in HCC following multiple ablation},
  journal = {Liver International},
  year = {2025},
  doi = {10.1111/liv.16051}
}
Kostenlos starten →